October 5, 2026Stocks·Bullish·healthcare
Psyence Biomedical signs manufacturing agreement with DEA-registered Benuvia for U.S. pharmaceutical-grade ibogaine API
Psyence Biomedical signed a manufacturing services agreement with DEA-registered Benuvia for planned U.S. manufacture of pharmaceutical-grade ibogaine active pharmaceutical ingredient.
Detected & updated continuously · Source: Nebula
Story subjects